SCHEMBL25677754

SCHEMBL25677754

c1ccc(-c2nc(-c3ccc(-c4ccc5ccccc5c4)cc3)nc(-c3cccc4oc5c6ccccc6c(-c6ccccc6)cc5c34)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.39
▸ KDM4E B2RXH2 4/20 0.39
▸ HSD17B10 Q99714 3/20 0.39
▸ TP53 P04637 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ ALOX5 P09917 1/20 0.36
▸ MAPT P10636 6/20 0.35
▸ TSHR P16473 3/20 0.35
▸ HPGD P15428 2/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ NFKB1 P19838 1/20 0.35
▸ NFKB2 Q00653 1/20 0.35
▸ RELA Q04206 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ CYP1A1 P04798 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24585627 1.00 ALDH1A1 (0.39) ALDH1A1KDM4EHSD17B10TP53SMN1; SMN2
SCHEMBL25677900 0.97 ALDH1A1 (0.39) ALDH1A1KDM4EHSD17B10TP53SMN1; SMN2
SCHEMBL26244329 0.97 ALDH1A1 (0.39) ALDH1A1KDM4EHSD17B10TP53SMN1; SMN2
SCHEMBL25679422 0.95 ALDH1A1 (0.39) ALDH1A1KDM4EHSD17B10TP53SMN1; SMN2
SCHEMBL25679332 0.95 ALDH1A1 (0.39) ALDH1A1KDM4EHSD17B10TP53SMN1; SMN2
SCHEMBL25683492 0.95 ALDH1A1 (0.39) ALDH1A1KDM4EHSD17B10TP53SMN1; SMN2
SCHEMBL25677901 0.95 ALDH1A1 (0.40) ALDH1A1KDM4EHSD17B10TP53SMN1; SMN2
SCHEMBL26243955 0.94 ALDH1A1 (0.38) ALDH1A1KDM4EHSD17B10TP53SMN1; SMN2
SCHEMBL24521339 0.94 ALDH1A1 (0.39) ALDH1A1KDM4EHSD17B10TP53SMN1; SMN2
SCHEMBL23034173 0.93 ALDH1A1 (0.37) ALDH1A1KDM4EHSD17B10TP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230292601-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-09-14 — — US disclosed
US-20230292601-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-09-14 — — US disclosed
EP-4201931-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-06-28 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230292601-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME ORC3, CRY1, SUN2 ALDH1A1 458/4885KDM4E 2700/4885HSD17B10 2669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback